{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T09:17:30Z","timestamp":1787735850417,"version":"build-2784847793"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Jiangsu Province Capability Improvement Project through Science, Technology and Education","award":["ZDXK202248"],"award-info":[{"award-number":["ZDXK202248"]}]},{"name":"Jiangsu Province Frontier Technology R&D Program","award":["BF2025615"],"award-info":[{"award-number":["BF2025615"]}]},{"name":"the Specialized Diseases Clinical Research Fund of Jiangsu Province Hospital","award":["DL202411"],"award-info":[{"award-number":["DL202411"]}]},{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2024ZD0524403"],"award-info":[{"award-number":["2024ZD0524403"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"DOI":"10.1186\/s13098-026-02279-w","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T13:13:21Z","timestamp":1787663601000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between low skeletal muscle mass assessed by deep learning-based CT and MASLD: a prospective cohort study"],"prefix":"10.1186","volume":"18","author":[{"given":"Yaping","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiulou","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumei","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyuan","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentao","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengxiao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ci","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7193-2927","authenticated-orcid":false,"given":"Qun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"issue":"1","key":"2279_CR1","doi-asserted-by":"publisher","first-page":"101133","DOI":"10.1016\/j.aohep.2023.101133","volume":"29","author":"ME Rinella","year":"2024","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Ann Hepatol. 2024;29(1):101133.","journal-title":"Ann Hepatol"},{"issue":"4","key":"2279_CR2","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023;77(4):1335\u201347.","journal-title":"Hepatology"},{"key":"2279_CR3","doi-asserted-by":"publisher","first-page":"110993","DOI":"10.1016\/j.diabres.2023.110993","volume":"206","author":"X Ni","year":"2023","unstructured":"Ni X, Tong C, Halengbieke A, Cao T, Tang J, Tao L, et al. Association between nonalcoholic fatty liver disease and type 2 diabetes: A bidirectional two-sample mendelian randomization study. Diabetes Res Clin Pract. 2023;206:110993.","journal-title":"Diabetes Res Clin Pract"},{"key":"2279_CR4","doi-asserted-by":"crossref","unstructured":"Chen H, Liu Y, Liu D, Liang Y, Zhu Z, Dong K et al. Sex- and age-specific associations between abdominal fat and non-alcoholic fatty liver disease: a prospective cohort study. J Mol Cell Biol. 2024;15(11).","DOI":"10.1093\/jmcb\/mjad069"},{"issue":"4","key":"2279_CR5","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/CM9.0000000000002753","volume":"137","author":"M Yuan","year":"2024","unstructured":"Yuan M, He J, Hu X, Yao L, Chen P, Wang Z, et al. Hypertension and NAFLD risk: Insights from the NHANES 2017\u20132018 and Mendelian randomization analyses. Chin Med J (Engl). 2024;137(4):457\u201364.","journal-title":"Chin Med J (Engl)"},{"issue":"Suppl","key":"2279_CR6","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","volume":"31","author":"ZM Younossi","year":"2025","unstructured":"Younossi ZM, Kalligeros M, Henry L. Epidemiology of metabolic dysfunction-associated steatotic liver disease. Clin Mol Hepatol. 2025;31(Suppl):S32\u201350.","journal-title":"Clin Mol Hepatol"},{"issue":"4","key":"2279_CR7","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","volume":"18","author":"DQ Huang","year":"2021","unstructured":"Huang DQ, El-Serag HB, Loomba R. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2021;18(4):223\u201338.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2279_CR8","doi-asserted-by":"crossref","unstructured":"Tomeno W, Imajo K, Takayanagi T, Ebisawa Y, Seita K, Takimoto T et al. Complications of Non-Alcoholic Fatty Liver Disease in Extrahepatic Organs. Diagnostics (Basel). 2020;10(11):912.","DOI":"10.3390\/diagnostics10110912"},{"issue":"2","key":"2279_CR9","doi-asserted-by":"publisher","first-page":"329","DOI":"10.14218\/JCTH.2021.00178","volume":"10","author":"E Kaya","year":"2022","unstructured":"Kaya E, Yilmaz Y. Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the Liver. J Clin Transl Hepatol. 2022;10(2):329\u201338.","journal-title":"J Clin Transl Hepatol"},{"key":"2279_CR10","doi-asserted-by":"publisher","first-page":"109199","DOI":"10.1016\/j.cbi.2020.109199","volume":"330","author":"CY Lian","year":"2020","unstructured":"Lian CY, Zhai ZZ, Li ZF, Wang L. High fat diet-triggered non-alcoholic fatty liver disease: A review of proposed mechanisms. Chem Biol Interact. 2020;330:109199.","journal-title":"Chem Biol Interact"},{"issue":"5","key":"2279_CR11","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1002\/jcsm.13543","volume":"15","author":"MJ Kim","year":"2024","unstructured":"Kim MJ, Cho YK, Kim EH, Lee MJ, Lee WJ, Kim HK, et al. Association between metabolic dysfunction-associated steatotic liver disease and myosteatosis measured by computed tomography. J Cachexia Sarcopenia Muscle. 2024;15(5):1942\u201352.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"4","key":"2279_CR12","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1210\/endrev\/bnaa016","volume":"41","author":"MCK Severinsen","year":"2020","unstructured":"Severinsen MCK, Pedersen BK. Muscle-Organ Crosstalk: The Emerging Roles of Myokines. Endocr Rev. 2020;41(4):594\u2013609.","journal-title":"Endocr Rev"},{"issue":"2","key":"2279_CR13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/cld.900","volume":"16","author":"AA Li","year":"2020","unstructured":"Li AA, Kim D, Ahmed A. Association of Sarcopenia and NAFLD: An Overview. Clin Liver Dis (Hoboken). 2020;16(2):73\u20136.","journal-title":"Clin Liver Dis (Hoboken)"},{"issue":"4","key":"2279_CR14","doi-asserted-by":"publisher","first-page":"987","DOI":"10.3350\/cmh.2023.0035","volume":"29","author":"HK Kim","year":"2023","unstructured":"Kim HK, Bae SJ, Lee MJ, Kim EH, Park H, Kim HS, et al. Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity. Clin Mol Hepatol. 2023;29(4):987\u20131001.","journal-title":"Clin Mol Hepatol"},{"issue":"1","key":"2279_CR15","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/jcsm.13125","volume":"14","author":"HJ Choe","year":"2023","unstructured":"Choe HJ, Lee H, Lee D, Kwak SH, Koo BK. Different effects of low muscle mass on the risk of non-alcoholic fatty liver disease and hepatic fibrosis in a prospective cohort. J Cachexia Sarcopenia Muscle. 2023;14(1):260\u20139.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"2279_CR16","doi-asserted-by":"publisher","first-page":"19883","DOI":"10.1038\/s41598-024-71096-w","volume":"14","author":"X Tantai","year":"2024","unstructured":"Tantai X, Ran Q, Wen Z, Tuo S, Liu N, Dai S, et al. Low muscle quality index is associated with increased risk of advanced fibrosis in adult patients with nonalcoholic fatty liver disease: NHANES 2011\u20132014. Sci Rep. 2024;14(1):19883.","journal-title":"Sci Rep"},{"key":"2279_CR17","doi-asserted-by":"publisher","first-page":"101696","DOI":"10.1016\/j.arr.2022.101696","volume":"80","author":"MS Kuchay","year":"2022","unstructured":"Kuchay MS, Mart\u00ednez-Montoro JI, Kaur P, Fern\u00e1ndez-Garc\u00eda JC, Ramos-Molina B. Non-alcoholic fatty liver disease-related fibrosis and sarcopenia: An altered liver-muscle crosstalk leading to increased mortality risk. Ageing Res Rev. 2022;80:101696.","journal-title":"Ageing Res Rev"},{"issue":"8","key":"2279_CR18","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1111\/liv.14852","volume":"41","author":"D Kim","year":"2021","unstructured":"Kim D, Wijarnpreecha K, Sandhu KK, Cholankeril G, Ahmed A. Sarcopenia in nonalcoholic fatty liver disease and all-cause and cause-specific mortality in the United States. Liver Int. 2021;41(8):1832\u201340.","journal-title":"Liver Int"},{"issue":"5","key":"2279_CR19","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1002\/jcsm.12754","volume":"12","author":"HS Chun","year":"2021","unstructured":"Chun HS, Kim MN, Lee JS, Lee HW, Kim BK, Park JY, et al. Risk stratification using sarcopenia status among subjects with metabolic dysfunction-associated fatty liver disease. J Cachexia Sarcopenia Muscle. 2021;12(5):1168\u201378.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"4","key":"2279_CR20","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1007\/s00330-019-06573-2","volume":"30","author":"D Albano","year":"2020","unstructured":"Albano D, Messina C, Vitale J, Sconfienza LM. Imaging of sarcopenia: old evidence and new insights. Eur Radiol. 2020;30(4):2199\u2013208.","journal-title":"Eur Radiol"},{"issue":"1","key":"2279_CR21","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/jcsm.13158","volume":"14","author":"J Keyl","year":"2023","unstructured":"Keyl J, Hosch R, Berger A, Ester O, Greiner T, Bogner S, et al. Deep learning-based assessment of body composition and liver tumour burden for survival modelling in advanced colorectal cancer. J Cachexia Sarcopenia Muscle. 2023;14(1):545\u201352.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2279_CR22","doi-asserted-by":"crossref","unstructured":"Ackermans L, Volmer L, Wee L, Brecheisen R, S\u00e1nchez-Gonz\u00e1lez P, Seiffert AP et al. Deep Learning Automated Segmentation for Muscle and Adipose Tissue from Abdominal Computed Tomography in Polytrauma Patients. Sens (Basel). 2021;21(6):2083.","DOI":"10.3390\/s21062083"},{"issue":"3","key":"2279_CR23","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s00256-019-03289-8","volume":"49","author":"R Hemke","year":"2020","unstructured":"Hemke R, Buckless CG, Tsao A, Wang B, Torriani M. Deep learning for automated segmentation of pelvic muscles, fat, and bone from CT studies for body composition assessment. Skeletal Radiol. 2020;49(3):387\u201395.","journal-title":"Skeletal Radiol"},{"issue":"1","key":"2279_CR24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13578-025-01469-9","volume":"15","author":"SW Hsu","year":"2025","unstructured":"Hsu SW, Lin MR, Chou WH, Wan YY, Kao WY, Chang WC. Cross-ancestry discovery of genetic risk variants for lean metabolic dysfunction-associated steatotic liver disease. Cell Biosci. 2025;15(1):131.","journal-title":"Cell Biosci"},{"issue":"2","key":"2279_CR25","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s12072-024-10769-0","volume":"19","author":"SW Wang","year":"2025","unstructured":"Wang SW, Wang C, Cheng YM, Chen CY, Hsieh TH, Wang CC, et al. Genetic predisposition of metabolic dysfunction-associated steatotic liver disease: a population-based genome-wide association study. Hepatol Int. 2025;19(2):415\u201327.","journal-title":"Hepatol Int"},{"issue":"1","key":"2279_CR26","doi-asserted-by":"publisher","first-page":"101761","DOI":"10.1016\/j.aohep.2024.101761","volume":"30","author":"CW Lu","year":"2025","unstructured":"Lu CW, Chou TJ, Wu TY, Lee YH, Yang HJ, Huang KC. PNPLA3 and SAMM50 variants are associated with lean nonalcoholic fatty liver disease in Asian population. Ann Hepatol. 2025;30(1):101761.","journal-title":"Ann Hepatol"},{"issue":"4","key":"2279_CR27","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1159\/000539371","volume":"17","author":"EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic","year":"2024","unstructured":"EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic. Dysfunction-Associated Steatotic Liver Disease (MASLD). Obes Facts. 2024;17(4):374\u2013444.","journal-title":"Obes Facts"},{"issue":"9","key":"2279_CR28","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1016\/j.clnu.2024.07.006","volume":"43","author":"X Li","year":"2024","unstructured":"Li X, He J, Sun Q. The prevalence and effects of sarcopenia in patients with metabolic dysfunction-associated steatotic liver disease (MASLD): A systematic review and meta-analysis. Clin Nutr. 2024;43(9):2005\u201316.","journal-title":"Clin Nutr"},{"issue":"1164","key":"2279_CR29","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1093\/bjr\/tqae191","volume":"97","author":"DPJ van Dijk","year":"2024","unstructured":"van Dijk DPJ, Volmer LF, Brecheisen R, Martens B, Dolan RD, Bryce AS, et al. External validation of a deep learning model for automatic segmentation of skeletal muscle and adipose tissue on abdominal CT images. Br J Radiol. 2024;97(1164):2015\u201323.","journal-title":"Br J Radiol"},{"key":"2279_CR30","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.compbiomed.2017.05.018","volume":"87","author":"S Belharbi","year":"2017","unstructured":"Belharbi S, Chatelain C, H\u00e9rault R, Adam S, Thureau S, Chastan M, et al. Spotting L3 slice in CT scans using deep convolutional network and transfer learning. Comput Biol Med. 2017;87:95\u2013103.","journal-title":"Comput Biol Med"},{"issue":"6","key":"2279_CR31","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1001\/jamaoncol.2024.1120","volume":"10","author":"TL Chaunzwa","year":"2024","unstructured":"Chaunzwa TL, Qian JM, Li Q, Ricciuti B, Nuernberg L, Johnson JW, et al. Body Composition in Advanced Non-Small Cell Lung Cancer Treated With Immunotherapy. JAMA Oncol. 2024;10(6):773\u201383.","journal-title":"JAMA Oncol"},{"issue":"2","key":"2279_CR32","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1148\/radiol.2020201640","volume":"298","author":"K Magudia","year":"2021","unstructured":"Magudia K, Bridge CP, Bay CP, Babic A, Fintelmann FJ, Troschel FM, et al. Population-Scale CT-based Body Composition Analysis of a Large Outpatient Population Using Deep Learning to Derive Age-, Sex-, and Race-specific Reference Curves. Radiology. 2021;298(2):319\u201329.","journal-title":"Radiology"},{"issue":"3","key":"2279_CR33","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.cgh.2021.04.038","volume":"20","author":"S Moon","year":"2022","unstructured":"Moon S, Chung GE, Joo SK, Park JH, Chang MS, Yoon JW, et al. A PNPLA3 Polymorphism Confers Lower Susceptibility to Incident Diabetes Mellitus in Subjects With Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2022;20(3):682\u2013e918.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"2279_CR34","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41574-025-01197-7","volume":"22","author":"CH Liu","year":"2026","unstructured":"Liu CH, Zeng QM, Kim W, Kim SU, Younossi ZM, Targher G, et al. Sarcopenia and MASLD: novel insights and the future. Nat Rev Endocrinol. 2026;22(3):139\u201352.","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"2279_CR35","doi-asserted-by":"publisher","first-page":"e13569","DOI":"10.1111\/1753-0407.13569","volume":"16","author":"Z Mai","year":"2024","unstructured":"Mai Z, Chen Y, Mao H, Wang L. Association between the skeletal muscle mass to visceral fat area ratio and metabolic dysfunction-associated fatty liver disease: A cross-sectional study of NHANES 2017\u20132018. J Diabetes. 2024;16(6):e13569.","journal-title":"J Diabetes"},{"issue":"2","key":"2279_CR36","first-page":"121","volume":"14","author":"Y Song","year":"2026","unstructured":"Song Y, Liu Y, Jiang J, Zheng Y, Wang Z, Xie C, et al. Bidirectional Regulation between Metabolic Dysfunction-associated Steatotic Liver Disease and Sarcopenia via Liver-muscle Crosstalk. J Clin Transl Hepatol. 2026;14(2):121\u201336.","journal-title":"J Clin Transl Hepatol"},{"issue":"Suppl","key":"2279_CR37","doi-asserted-by":"publisher","first-page":"S68","DOI":"10.3350\/cmh.2022.0358","volume":"29","author":"SK Joo","year":"2023","unstructured":"Joo SK, Kim W. Interaction between sarcopenia and nonalcoholic fatty liver disease. Clin Mol Hepatol. 2023;29(Suppl):S68\u201378.","journal-title":"Clin Mol Hepatol"},{"issue":"9","key":"2279_CR38","doi-asserted-by":"publisher","first-page":"7389","DOI":"10.1039\/D0FO01095B","volume":"11","author":"XF Guo","year":"2020","unstructured":"Guo XF, Wang C, Yang T, Li S, Li KL, Li D. Vitamin D and non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials. Food Funct. 2020;11(9):7389\u201399.","journal-title":"Food Funct"},{"issue":"4","key":"2279_CR39","doi-asserted-by":"publisher","first-page":"456","DOI":"10.7570\/jomes25009","volume":"34","author":"Y Xu","year":"2025","unstructured":"Xu Y, Hu T, Li X, Shen Y, Xiao Y, Wang Y, et al. Association between Relative Skeletal Muscle Mass and Metabolic Dysfunction-Associated Steatotic Liver Disease Development in a Community-Based Population. J Obes Metab Syndr. 2025;34(4):456\u201366.","journal-title":"J Obes Metab Syndr"},{"key":"2279_CR40","doi-asserted-by":"crossref","unstructured":"Huo Z, Chen Y, Huang Y, Yang Z, Long Y, Zhang Q et al. Long-term prognosis of lean MASLD: evidence from three population-based prospective cohorts. Gut. 2026;75(4):772-85.","DOI":"10.1136\/gutjnl-2025-336127"},{"issue":"2","key":"2279_CR41","doi-asserted-by":"publisher","first-page":"265","DOI":"10.33549\/physiolres.935164","volume":"73","author":"YL Qu","year":"2024","unstructured":"Qu YL, Song YH, Sun RR, Ma YJ, Zhang Y. Serum Vitamin D Level in Overweight Individuals and Its Correlation With the Incidence of Non-alcoholic Fatty Liver Disease. Physiol Res. 2024;73(2):265\u201371.","journal-title":"Physiol Res"},{"key":"2279_CR42","doi-asserted-by":"publisher","first-page":"1026054","DOI":"10.3389\/fnut.2023.1026054","volume":"10","author":"Y Lu","year":"2023","unstructured":"Lu Y, Xia Q, Wu L, Xie Z. Gender difference in association between low muscle mass and risk of non-alcoholic fatty liver disease among Chinese adults with visceral obesity. Front Nutr. 2023;10:1026054.","journal-title":"Front Nutr"},{"issue":"11","key":"2279_CR43","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1017\/S0007114521002415","volume":"127","author":"G Li","year":"2022","unstructured":"Li G, Rios RS, Wang XX, Yu Y, Zheng KI, Huang OY, et al. Sex influences the association between appendicular skeletal muscle mass to visceral fat area ratio and non-alcoholic steatohepatitis in patients with biopsy-proven non-alcoholic fatty liver disease. Br J Nutr. 2022;127(11):1613\u201320.","journal-title":"Br J Nutr"},{"issue":"1","key":"2279_CR44","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1186\/s12876-023-02997-9","volume":"23","author":"YT Cao","year":"2023","unstructured":"Cao YT, Zhang WH, Lou Y, Yan QH, Zhang YJ, Qi F, et al. Sex- and reproductive status-specific relationships between body composition and non-alcoholic fatty liver disease. BMC Gastroenterol. 2023;23(1):364.","journal-title":"BMC Gastroenterol"},{"issue":"5","key":"2279_CR45","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1002\/hep.30049","volume":"68","author":"G Kim","year":"2018","unstructured":"Kim G, Lee SE, Lee YB, Jun JE, Ahn J, Bae JC, et al. Relationship Between Relative Skeletal Muscle Mass and Nonalcoholic Fatty Liver Disease: A 7-Year Longitudinal Study. Hepatology. 2018;68(5):1755\u201368.","journal-title":"Hepatology"},{"issue":"5","key":"2279_CR46","doi-asserted-by":"publisher","first-page":"e70056","DOI":"10.1002\/jcsm.70056","volume":"16","author":"H Qin","year":"2025","unstructured":"Qin H, Jiao W, Liao G. The Association of Low Muscle Mass With Serum Sex Hormones and Sex Hormone-Binding Globulin. J Cachexia Sarcopenia Muscle. 2025;16(5):e70056.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"10191","key":"2279_CR47","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1016\/S0140-6736(19)31138-9","volume":"393","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Sayer AA, Sarcopenia. Lancet. 2019;393(10191):2636\u201346.","journal-title":"Lancet"},{"issue":"1","key":"2279_CR48","doi-asserted-by":"publisher","first-page":"e210080","DOI":"10.1148\/ryai.210080","volume":"4","author":"CP Bridge","year":"2022","unstructured":"Bridge CP, Best TD, Wrobel MM, Marquardt JP, Magudia K, Javidan C, et al. A Fully Automated Deep Learning Pipeline for Multi-Vertebral Level Quantification and Characterization of Muscle and Adipose Tissue on Chest CT Scans. Radiol Artif Intell. 2022;4(1):e210080.","journal-title":"Radiol Artif Intell"},{"issue":"3","key":"2279_CR49","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1097\/MOG.0000000000000621","volume":"36","author":"A Khalifa","year":"2020","unstructured":"Khalifa A, Rockey DC. The utility of liver biopsy in 2020. Curr Opin Gastroenterol. 2020;36(3):184\u201391.","journal-title":"Curr Opin Gastroenterol"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-026-02279-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-026-02279-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-026-02279-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T08:17:57Z","timestamp":1787732277000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13098-026-02279-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2279"],"URL":"https:\/\/doi.org\/10.1186\/s13098-026-02279-w","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"assertion":[{"value":"4 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Decla-ration of Helsinki (as revised in 2024). The research protocol was approved by the Ethics Committee of the First Affiliated Hospital of Nanjing Medical University (2019-SR-209). All participants provided written informed consent.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"186"}}